hexamethonium has been researched along with natriuretic peptide, c-type in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McKendry, J; Montpetit, CJ; Perry, SF | 1 |
Bianciotti, LG; Corbo, NS; RodrÃguez, MR; Sabbatini, ME; Vatta, MS | 1 |
2 other study(ies) available for hexamethonium and natriuretic peptide, c-type
Article | Year |
---|---|
The effects of C-type natriuretic peptide on catecholamine release in the pacific spiny dogfish (Squalus acanthias).
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Dogfish; Epinephrine; Female; Hexamethonium; Kinetics; Lisinopril; Male; Natriuretic Peptide, C-Type; Nicotinic Antagonists; Norepinephrine; Receptors, Nicotinic | 2001 |
C-type natriuretic peptide applied to the brain enhances exocrine pancreatic secretion through a vagal pathway.
Topics: Animals; Atrial Natriuretic Factor; Atropine; Brain; Cyclic GMP; Drug Interactions; Enzyme Inhibitors; Ganglionic Blockers; Hexamethonium; Natriuretic Peptide, C-Type; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pancreas; Parasympatholytics; Peptide Fragments; Proteins; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor; Secretin; Sincalide; Thionucleotides; Time Factors; Vagotomy; Vagus Nerve; Vasoactive Intestinal Peptide | 2005 |